Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors - Sule, Amrita; Van Doorn, Jinny; Sundaram, Ranjini K; Ganesa, Sachita; Vasquez, Juan C; Bindra, Ranjit S (NAR cancer, 2021)
Keywords: Editor's Choice; Nucleic Acid-Based Cancer Therapeutics